Novo Nordisk

Novo Nordisk is a global healthcare company headquartered in Denmark, renowned for its leadership in diabetes care and chronic disease management. With a century-long legacy of innovation, the company develops cutting-edge treatments for diabetes, obesity, rare blood disorders, and growth hormone deficiencies. Novo Nordisk focuses on improving patient outcomes through advanced therapies, research, and sustainable healthcare solutions. Committed to addressing global health challenges, the company collaborates with partners to enhance access to care worldwide. Guided by its purpose, “Driving change to defeat diabetes and other serious chronic diseases,” Novo Nordisk strives to improve lives and create a healthier future.